Latest Breaking News On - Strategic innovation leaders - Page 1 : comparemela.com

DALLAS (BUSINESS WIRE) Secretome Therapeutics, a preclinical company developing novel therapies derived from neonatal mesenchymal stem cells, today announced the appointment of Angela Shen, M.D., M.B.A, to its Board of Directors.Dr. Shen is currently the Vice President, Strategic Innovation Leaders at Mass General.

New yorkUnited statesAlbany medical collegeAngela shenVinny jindalUniversity of pennsylvaniaStern school of businessSecretome therapeuticsVice presidentStrategic innovation leadersMass general brighamChief medical officerWalking fishSecretome therapeutic presidentChief executive